J0887 Epoetin Beta (HCPCS) Reimbursement | OpenPayer

Summary & Overview

HCPCS J0887: Epoetin Beta Injection for ESRD on Dialysis

HCPCS Level II code J0887 denotes an injectable dose of epoetin beta, 1 microgram, used for anemia management in patients with end-stage renal disease receiving dialysis. As an HCPCS Level II pharmacologic code, J0887 identifies a specific biologic therapy administered in dialysis or outpatient infusion settings and is relevant to payer coverage, billing accuracy, and dialysis care protocols nationwide. Nationally, anemia treatment in dialysis populations represents a consistent component of renal care and drives recurring medication administration and billing activity.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code signifies clinically and operationally, typical sites of service, and the payer landscape covered. The publication provides benchmarks and billing considerations for J0887, outlines common billing modifiers and coding contexts (where available), and situates the code within clinical practice for ESRD on-dialysis anemia management. This resource is intended for billing professionals, renal clinicians, and policy analysts seeking concise reference material about HCPCS Level II code J0887 and its role in dialysis-related medication administration and payer interactions.

Data not available in the input for specific payer rates, associated taxonomies, ICD-10 pairings, and related codes.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ0887HCPCS Level IIepoetin betaESRDdialysisinjectable therapyanemia managementpharmacologic therapy

Billing Code Overview

HCPCS Level II code J0887 represents an injection of epoetin beta, 1 microgram, specifically indicated for end-stage renal disease (ESRD) patients on dialysis. The service is a pharmacologic therapy administered by injection and is typically provided in dialysis centers or other infusion/clinic settings where dialysis patients receive treatment.

Service Type: Injectable biologic therapy for anemia management in ESRD on dialysis

Typical Site of Service: Dialysis center or outpatient infusion/clinic setting

Clinical & Coding Specifications

Clinical Context

A typical patient is a 58-year-old with end-stage renal disease (ESRD) receiving maintenance hemodialysis three times weekly at an outpatient dialysis center. The patient has symptomatic anemia related to chronic kidney disease and is prescribed erythropoiesis-stimulating therapy. At the dialysis session the nurse reviews hemoglobin results, verifies medication order for epoetin beta, prepares the syringe, and documents dose in the dialysis flow sheet. The medication is administered intravenously during dialysis via the access line. Vital signs are monitored pre- and post-administration and the dose (in micrograms) is recorded for billing using the HCPCS Level II code J0887 representing injection, epoetin beta, 1 microgram, specifically for ESRD on dialysis. The clinical workflow includes physician/nephrologist order entry, pharmacy verification and compounding as needed, nursing administration during the dialysis encounter, and documentation for medical necessity and coverage determination.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier/Unmodified service	Used when no special circumstances apply; many payors treat `00` as default.

Related Codes

HCPCS-J2780-RANITIDINE-INJECTION-25MG

HCPCS Level II J2780: Injection of Ranitidine Hydrochloride, 25 mg

HCPCS-J1850-KANAMYCIN-INJECTION-75MG

HCPCS Level II J1850: Injection, kanamycin sulfate, up to 75 mg

HCPCS-J2777-FARICIMAB-INTRAVITREAL-INJECTION-0-1-MG

HCPCS Level II J2777: Faricimab-svoa injection, 0.1 mg

HCPCS-J7303-CONTRACEPTIVE-HORMONE-VAGINAL-RING

HCPCS J7303: Contraceptive Supply, Hormone-Containing Vaginal Ring

HCPCS-J0136-ACETAMINOPHEN-INJECTION-10MG

HCPCS J0136: Injectable Acetaminophen (B. Braun), 10 mg

HCPCS-J2427-PALIPERIDONE-PALMITATE-EXTENDED-RELEASE-INJECTION

HCPCS J2427: Paliperidone Palmitate Extended-Release Injection, 1 mg

HCPCS-J0702-BETAMETHASONE-INJECTION-3MG-ACETATE-SODIUM-PHOSPHATE

HCPCS J0702: Betamethasone Injection, Acetate 3 mg / Sodium Phosphate 3 mg

HCPCS-J2265-MINOCYCLINE-INJECTION-1MG

HCPCS Level II J2265: Injection, Minocycline Hydrochloride, 1 mg

HCPCS-J7401-MOMETASONE-SINUS-IMPLANT-10MCG

HCPCS Level II J7401: Mometasone Furoate Sinus Implant, 10 mcg

HCPCS-J7658-ISOPROTERENOL-INHALATION-SOLUTION-DME

HCPCS Level II J7658: Isoproterenol HCl Inhalation Solution, Concentrated

Showing 1–10 of 991

Taxonomy Code	Specialty	Notes
`2080S0003X`	Nephrology	Nephrologists prescribe and manage ESA therapy for dialysis-dependent ESRD.
`363L00000X`	Dialysis Clinic/Center	Dialysis center nursing staff administer ESA during dialysis sessions.
`207P00000X`	Internal Medicine	Hospitalists or internists often manage chronic disease and ESA orders in inpatient/clinic settings.
`163W00000X`	Hematology	Hematologists may consult on anemia management when complex or refractory to standard ESA therapy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N18.6`	End stage renal disease	Primary indication for dialysis-dependent epoetin beta use; ESA therapy is standard for managing anemia in ESRD on dialysis.
`D63.1`	Anemia in chronic kidney disease	Direct clinical indication for erythropoiesis-stimulating agents like epoetin beta to reduce transfusion needs and treat symptomatic anemia.
`N18.5`	Chronic kidney disease, stage 5	Advanced CKD often progresses to ESRD; ESA therapy may be initiated in late-stage CKD and continued on dialysis.
`D50.9`	Iron deficiency anemia, unspecified	Coexisting iron deficiency can affect ESA responsiveness; often evaluated before or during ESA therapy.
`E83.11`	Iron deficiency due to blood loss (if applicable)	Iron status assessment is needed to optimize response to epoetin beta; iron deficiency is a common contributor to anemia in dialysis patients.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used when epoetin beta is administered subcutaneously rather than intravenously; documents injection technique when performed outside dialysis access line.
`36415`	Collection of venous blood by venipuncture	Often performed to obtain hemoglobin/hematocrit labs that guide ESA dosing prior to administration.
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when an ESA or related IV therapy requires an infusion time billing rather than a simple injection; uncommon for epoetin beta dosing during dialysis but applicable when infusions are extended.
`99406`	Smoking and tobacco use cessation counseling, intermediate (3-10 minutes)	Example chronic care counseling code that may be billed during comprehensive dialysis visits; not specific to ESA but commonly performed in the same care episode.
`G0317`	ESRD related monthly capitation/administration (Medicare)	Represents ESRD-related services and facility-based monthly ESRD payments; epoetin beta administrations are typically billed in the context of ESRD facility services and aligned with facility billing/capitation arrangements.